Birdwatch Note Rating
2023-03-16 00:42:44 UTC - HELPFUL
Rated by Participant: 7DEEC36B5360A0DCBDB34CDE103FA6264F8466DEC40320BA75F371060BA19C98
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details